OppenheimerFunds, Inc. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 133 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
OppenheimerFunds, Inc. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$12,850,000
+11.7%
5,000,0000.0%0.02%0.0%
Q4 2018$11,500,000
-28.3%
5,000,0000.0%0.02%
-15.8%
Q3 2018$16,050,000
+13.4%
5,000,0000.0%0.02%
+11.8%
Q2 2018$14,150,000
-20.3%
5,000,000
-0.3%
0.02%
-22.7%
Q1 2018$17,748,000
-8.7%
5,013,679
+0.1%
0.02%
-4.3%
Q4 2017$19,439,000
+53.0%
5,010,160
+0.2%
0.02%
+43.8%
Q3 2017$12,705,000
-7.0%
5,002,084
-0.0%
0.02%
-5.9%
Q2 2017$13,658,000
-17.5%
5,002,881
+0.0%
0.02%
-15.0%
Q1 2017$16,555,000
+39.1%
5,001,566
+0.0%
0.02%
+33.3%
Q4 2016$11,900,000
-35.1%
5,000,0000.0%0.02%
-34.8%
Q3 2016$18,350,000
+64.6%
5,000,0000.0%0.02%
+53.3%
Q2 2016$11,150,000
+7.2%
5,000,0000.0%0.02%
+7.1%
Q1 2016$10,400,000
-65.7%
5,000,000
-50.0%
0.01%
-26.3%
Q4 2015$30,300,000
+145.3%
10,000,000
+100.0%
0.02%
+11.8%
Q3 2015$12,350,000
-23.1%
5,000,0000.0%0.02%
-5.6%
Q2 2015$16,050,000
-10.1%
5,000,0000.0%0.02%
-10.0%
Q1 2015$17,850,000
+57.3%
5,000,0000.0%0.02%
+53.8%
Q4 2014$11,350,000
+17.0%
5,000,0000.0%0.01%
+18.2%
Q3 2014$9,700,000
-46.6%
5,000,0000.0%0.01%
-45.0%
Q2 2014$18,150,000
-6.4%
5,000,0000.0%0.02%
-13.0%
Q1 2014$19,400,000
+36.1%
5,000,0000.0%0.02%
+35.3%
Q4 2013$14,250,000
-33.7%
5,000,000
-16.7%
0.02%
-39.3%
Q3 2013$21,480,000
+7.2%
6,000,0000.0%0.03%
-3.4%
Q2 2013$20,040,000
-75.4%
6,000,000
-50.0%
0.03%
-52.5%
Q1 2013$81,480,00012,000,0000.06%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders